Alan Bash serves as the Interim Chief Executive Officer of Legend Biotech Corporation. Having previously managed the commercial rollout and leadership of the company's CARVYKTI business unit, he stepped into the interim CEO role following executive leadership transitions to guide the commercial-stage cell therapy enterprise through its next phases of global oncology expansion.